ScoreWhy is Arcoma AB ?
1
The company has declared negative results in Dec'2024 after 6 consecutive positive quarters
- NET PROFIT(9M) At SEK 2.99 MM has Grown at -52.35%
- OPERATING CASH FLOW(Y) Lowest at SEK 18.72 MM
- INTEREST COVERAGE RATIO(Q) Lowest at 13,970.37
2
With ROE of 8.26%, it has a fair valuation with a 2.14 Price to Book Value
- Over the past year, while the stock has generated a return of -16.10%, its profits have fallen by -60%
3
Underperformed the market in the last 1 year
- Even though the market (OMX Stockholm 30) has generated returns of 10.97% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -16.10% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Arcoma AB should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Arcoma AB for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Arcoma AB
-16.1%
-1.05
43.33%
OMX Stockholm 30
10.97%
0.59
18.59%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.18%
EBIT Growth (5y)
18.40%
EBIT to Interest (avg)
3.04
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
2.60
Tax Ratio
26.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.35%
ROE (avg)
6.76%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
2.14
EV to EBIT
10.70
EV to EBITDA
6.32
EV to Capital Employed
2.51
EV to Sales
0.87
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.44%
ROE (Latest)
8.26%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bearish
Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
CASH AND EQV(HY)
Highest at SEK 59.2 MM
-11What is not working for the Company
NET PROFIT(9M)
At SEK 2.99 MM has Grown at -52.35%
OPERATING CASH FLOW(Y)
Lowest at SEK 18.72 MM
INTEREST COVERAGE RATIO(Q)
Lowest at 13,970.37
RAW MATERIAL COST(Y)
Grown by 10.76% (YoY
DEBT-EQUITY RATIO
(HY)
Highest at 0 %
Here's what is working for Arcoma AB
Cash and Eqv
Highest at SEK 59.2 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Arcoma AB
Net Profit
At SEK 2.99 MM has Grown at -52.35%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (SEK MM)
Operating Cash Flow
Lowest at SEK 18.72 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (SEK MM)
Interest Coverage Ratio
Lowest at 13,970.37
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Debt-Equity Ratio
Highest at 0 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Raw Material Cost
Grown by 10.76% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
